SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001513162-20-000171
Filing Date
2020-08-17
Accepted
2020-08-17 16:17:29
Documents
1
Period of Report
2020-08-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3962
  Complete submission text file 0001513162-20-000171.txt   5524
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Issuer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEOLUS PHARMACEUTICALS, INC. 23811 INVERNESS PLACE LAGUNA NIGUEL CA 92677
Business Address
Cavalier David (Reporting) CIK: 0001289783 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37492 | Film No.: 201110307